331 related articles for article (PubMed ID: 8828766)
1. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of new surface coatings for extracorporeal circulation.
Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
6. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647
[TBL] [Abstract][Full Text] [Related]
8. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
Pekna M; Borowiec J; Fagerhol MK; Venge P; Thelin S
Scand J Thorac Cardiovasc Surg; 1994; 28(1):5-11. PubMed ID: 7939508
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
13. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
[TBL] [Abstract][Full Text] [Related]
14. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
[TBL] [Abstract][Full Text] [Related]
15. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
16. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
Bozdayi M; Borowiec J; Nilsson L; Venge P; Thelin S; Hansson HE
Artif Organs; 1996 Sep; 20(9):1008-16. PubMed ID: 8864022
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
19. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
[TBL] [Abstract][Full Text] [Related]
20. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
